| human | Q5 |
| P2456 | DBLP author ID | 14/5854 |
| P2798 | Loop ID | 210470 |
| P856 | official website | https://pureprojects.ppad.man.ac.uk/portal/en/researchers/david-wedge(ee1d8c86-2cdb-47c7-aa49-d2007ad553a0).html |
| P496 | ORCID iD | 0000-0002-7572-3196 |
| P1153 | Scopus author ID | 13205301200 |
| P69 | educated at | Manchester Metropolitan University | Q1888771 |
| P108 | employer | University of Oxford | Q34433 |
| University of Manchester | Q230899 | ||
| Wellcome Sanger Institute | Q1142544 | ||
| P734 | family name | Wedge | Q30669630 |
| Wedge | Q30669630 | ||
| Wedge | Q30669630 | ||
| P735 | given name | David | Q18057751 |
| David | Q18057751 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q92527983 | A community effort to create standards for evaluating tumor subclonal reconstruction |
| Q62657927 | A comparison of Raman and FT-IR spectroscopy for the prediction of meat spoilage |
| Q30857696 | A comparison of different chemometrics approaches for the robust classification of electronic nose data. |
| Q112565337 | A unified haplotype-based method for accurate and comprehensive variant calling |
| Q62657889 | A unified haplotype-based method for accurate and comprehensive variant calling |
| Q38352043 | Analysis of a complete DNA-protein affinity landscape |
| Q35235374 | Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue |
| Q42370830 | Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data |
| Q38354972 | Aptamer evolution for array-based diagnostics |
| Q38358691 | Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape |
| Q34062924 | Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer |
| Q91117991 | Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences |
| Q60044516 | Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors |
| Q61443309 | Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors |
| Q34164910 | Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets |
| Q56974314 | Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets |
| Q112708836 | Benchmarking small-variant genotyping in polyploids |
| Q39451492 | CONSeQuence: prediction of reference peptides for absolute quantitative proteomics using consensus machine learning approaches |
| Q123557918 | Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes |
| Q37334716 | Clinical and biological implications of driver mutations in myelodysplastic syndromes |
| Q36666868 | Clock-like mutational processes in human somatic cells |
| Q28256331 | Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers |
| Q40907746 | Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo |
| Q42920087 | Convergent evolution to an aptamer observed in small populations on DNA microarrays |
| Q91522794 | DNA copy number motifs are strong and independent predictors of survival in breast cancer |
| Q42910845 | DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype |
| Q28283300 | Deciphering signatures of mutational processes operative in human cancer |
| Q36873834 | Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. |
| Q34508343 | Differential and limited expression of mutant alleles in multiple myeloma |
| Q37180537 | Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer |
| Q24595521 | Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone |
| Q36320344 | Effect of mutation order on myeloproliferative neoplasms |
| Q91736107 | Embryonal precursors of Wilms tumor |
| Q57694301 | Erratum: Corrigendum: Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue |
| Q62657919 | Erratum: Corrigendum: Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone |
| Q102373353 | Evolution and lineage dynamics of a transmissible cancer in Tasmanian devils |
| Q41847944 | FDRAnalysis: a tool for the integrated analysis of tandem mass spectrometry identification results from multiple search engines |
| Q62657942 | Fabrication of planar organic nanotransistors using low temperature thermal nanoimprint lithography for chemical sensor applications |
| Q41956222 | Fast randomization of large genomic datasets while preserving alteration counts |
| Q37094573 | Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma |
| Q95327114 | Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma |
| Q34030728 | Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer |
| Q42997512 | Genome sequencing of normal cells reveals developmental lineages and mutational processes |
| Q38623761 | Genomic Evolution of Breast Cancer Metastasis and Relapse |
| Q112716940 | Genomic and evolutionary classification of lung cancer in never smokers |
| Q99207829 | Genomic copy number predicts esophageal cancer years before transformation |
| Q92454107 | Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma |
| Q92832246 | Genomic landscape and chronological reconstruction of driver events in multiple myeloma |
| Q58721686 | Genomic patterns of progression in smoldering multiple myeloma |
| Q37528285 | Heterogeneity of genomic evolution and mutational profiles in multiple myeloma |
| Q39013706 | How Subclonal Modeling Is Changing the Metastatic Paradigm |
| Q51860397 | In silico modelling of directed evolution: Implications for experimental design and stepwise evolution. |
| Q112693523 | In utero origin of myelofibrosis presenting in adult monozygotic twins |
| Q43118556 | Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing |
| Q57010933 | Is Serum or Plasma More Appropriate for Intersubject Comparisons in Metabolomic Studies? An Assessment in Patients with Small-Cell Lung Cancer |
| Q34046731 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences |
| Q30573699 | Liquid chromatography-mass spectrometry calibration transfer and metabolomics data fusion |
| Q28834072 | Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer |
| Q35234637 | Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes |
| Q112639000 | Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity |
| Q98778477 | Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases |
| Q24620915 | Mutational processes molding the genomes of 21 breast cancers |
| Q28389573 | Mutational signatures of ionizing radiation in second malignancies |
| Q57817695 | Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo |
| Q57817701 | Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo |
| Q52839635 | Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. |
| Q55112557 | NATURAL PRODUCTS FOR PEST MANAGEMENT |
| Q58105756 | Neutral tumor evolution? |
| Q51937038 | On global-local artificial neural networks for function approximation. |
| Q57900923 | Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics |
| Q45988269 | Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. |
| Q89556828 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition |
| Q39341523 | Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality |
| Q46877568 | Phytotoxic Eremophilanes from Ligularia macrophylla |
| Q43656975 | Predictive models for population performance on real biological fitness landscapes |
| Q38922293 | Principles of Reconstructing the Subclonal Architecture of Cancers |
| Q92425490 | Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers |
| Q100503866 | Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy |
| Q38367298 | RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia |
| Q57743540 | Rapid parallel acquisition of somatic mutations afterNPM1in acute myeloid leukaemia evolution |
| Q33657848 | Recurrent PTPRB and PLCG1 mutations in angiosarcoma |
| Q33850534 | Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma |
| Q52584573 | Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. |
| Q24568313 | Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 |
| Q38886065 | Somatic mutations reveal asymmetric cellular dynamics in the early human embryo |
| Q34442770 | Spatial and temporal diversity in genomic instability processes defines lung cancer evolution |
| Q35847434 | Subclonal diversification of primary breast cancer revealed by multiregion sequencing |
| Q114067093 | Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity |
| Q36193230 | Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes |
| Q39527587 | The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma |
| Q57743557 | The Life History of 21 Breast Cancers |
| Q35548366 | The evolutionary history of lethal metastatic prostate cancer |
| Q58238423 | The evolutionary landscape of colorectal tumorigenesis |
| Q37697911 | The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models |
| Q29614637 | The landscape of cancer genes and mutational processes in breast cancer |
| Q29614642 | The life history of 21 breast cancers |
| Q59800663 | Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations |
| Q52321041 | Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. |
| Q28396153 | Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing |
| Q35407284 | Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. |
| Q34659187 | Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage |
| Q35752935 | Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin |
| Q35170678 | United States Department of Agriculture-Agricultural Research Service research on natural products for pest management |
| Q37722072 | Whole exome sequencing of adenoid cystic carcinoma |
| Q31147553 | ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data |
| Q62657947 | pKa Prediction from “Quantum Chemical Topology” Descriptors |
Search more.